Diagnos Inc.
ADK.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.64% | 1.07% | 13.65% | -7.51% | -15.96% |
| Total Depreciation and Amortization | -1.21% | 2.07% | 10.50% | -6.81% | -0.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.83% | 25.73% | 17.68% | -44.77% | 41.53% |
| Change in Net Operating Assets | 269.35% | 169.57% | 112.08% | 53.35% | -162.13% |
| Cash from Operations | -0.32% | 7.93% | 24.47% | -10.83% | -97.14% |
| Capital Expenditure | 81.48% | 3.57% | -64.71% | 43.33% | 42.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -307.28% | -18.25% | 580.04% | 54.35% | 51.50% |
| Cash from Investing | -307.92% | -18.28% | 575.57% | 54.29% | 51.46% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 68.49% | 77.10% | -133.28% | -519.48% | -11.38% |
| Issuance of Common Stock | -- | -- | -- | 25.57% | -38.76% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 36.58% | 1.53% | -18.84% | 19.33% | -0.94% |
| Cash from Financing | 3,194.46% | 83.47% | -143.80% | 10.53% | -42.30% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -125.38% | 1,169.01% | 67.72% | 104.22% | -215.96% |